EP1191845A4 - Prevention of brain damage in stroke - Google Patents

Prevention of brain damage in stroke

Info

Publication number
EP1191845A4
EP1191845A4 EP00923342A EP00923342A EP1191845A4 EP 1191845 A4 EP1191845 A4 EP 1191845A4 EP 00923342 A EP00923342 A EP 00923342A EP 00923342 A EP00923342 A EP 00923342A EP 1191845 A4 EP1191845 A4 EP 1191845A4
Authority
EP
European Patent Office
Prior art keywords
stroke
prevention
brain damage
brain
damage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00923342A
Other languages
German (de)
French (fr)
Other versions
EP1191845A1 (en
Inventor
Kevin J Tracey
Haichao Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
North Shore Long Island Jewish Research Institute
Original Assignee
North Shore Long Island Jewish Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by North Shore Long Island Jewish Research Institute filed Critical North Shore Long Island Jewish Research Institute
Publication of EP1191845A1 publication Critical patent/EP1191845A1/en
Publication of EP1191845A4 publication Critical patent/EP1191845A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP00923342A 1999-04-13 2000-04-13 Prevention of brain damage in stroke Withdrawn EP1191845A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12928899P 1999-04-13 1999-04-13
US129288P 1999-04-13
PCT/US2000/010002 WO2000060943A1 (en) 1999-04-13 2000-04-13 Prevention of brain damage in stroke

Publications (2)

Publication Number Publication Date
EP1191845A1 EP1191845A1 (en) 2002-04-03
EP1191845A4 true EP1191845A4 (en) 2002-07-17

Family

ID=22439301

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00923342A Withdrawn EP1191845A4 (en) 1999-04-13 2000-04-13 Prevention of brain damage in stroke

Country Status (5)

Country Link
EP (1) EP1191845A4 (en)
JP (1) JP2002541162A (en)
AU (1) AU766910B2 (en)
CA (1) CA2368937A1 (en)
WO (1) WO2000060943A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720311B2 (en) * 1997-12-18 2004-04-13 David Tsai Polypeptide for the treatment of cancer and a method for preparation thereof
US20030044400A1 (en) * 2001-05-22 2003-03-06 Jenny Yu Composition and method for treating cells
JP4426929B2 (en) * 2004-03-25 2010-03-03 株式会社アミンファーマ研究所 Screening method for stroke and asymptomatic cerebral infarction
AU2021234121A1 (en) 2020-03-11 2022-09-29 Universitaet Bern Fetuin A for treatment of renal disorders
CN118294673A (en) * 2024-04-03 2024-07-05 泰臻(江苏)生物科技有限公司 Application of histidine-rich glycoprotein in predicting, preventing or treating hemorrhage transformation after thrombolysis treatment of cerebral infarction patient

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992022309A1 (en) * 1991-06-18 1992-12-23 Zeneca Ltd. Use of 4-(4-chlorophenyl-sulphonylcarbamoyl) benzoyl-l-valyl-l-proline 1(rs)-(1-trifluoroacetyl-2-methylpropyl) amide in the treatment of vascular diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE520730C2 (en) * 1995-01-20 2003-08-19 Eskil Elmer Treatment of brain ischemia and brain damage with a neuroprotective drug

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992022309A1 (en) * 1991-06-18 1992-12-23 Zeneca Ltd. Use of 4-(4-chlorophenyl-sulphonylcarbamoyl) benzoyl-l-valyl-l-proline 1(rs)-(1-trifluoroacetyl-2-methylpropyl) amide in the treatment of vascular diseases

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HAICHAO WANG: "Fetuin protects the fetus from TNF", THE LANCET, vol. 350, 20 September 1997 (1997-09-20), pages 861 - 862, XP002912856 *
JANTU CHE ET AL.: "Prevention of cerebral infarction by fetuin", FASEB JOURNAL, vol. 13, no. 4 Part 1, 12 March 1999 (1999-03-12), pages A507, XP001064891 *
See also references of WO0060943A1 *

Also Published As

Publication number Publication date
AU4348500A (en) 2000-11-14
JP2002541162A (en) 2002-12-03
EP1191845A1 (en) 2002-04-03
WO2000060943A1 (en) 2000-10-19
CA2368937A1 (en) 2000-10-19
AU766910B2 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
GB2349091B (en) Defibrillator
HK1042224A1 (en) Punctum plug
EP1223932A4 (en) Compounds and methods
EP1146790A4 (en) Compounds and methods
PL353476A1 (en) Th2 differentiation inhibitors
GB2358375B (en) Tessellation set
EP1185171A4 (en) Compositions and methods comprising morphine gluconate
GB9905817D0 (en) Methods
EP1191845A4 (en) Prevention of brain damage in stroke
GB0026072D0 (en) Improvements in plugs
GB0007778D0 (en) Detection of brain damage
GB9918150D0 (en) Nuclease variant
EP1194439A4 (en) Human eag2
GB2358185B (en) Phyllosilicates
EP1158856A4 (en) Human fas
GB9908347D0 (en) Bedframe
GB0206401D0 (en) Side effects treatment
TW397124U (en) Secretive safe
AU137763S (en) Pedestal cylinder safe
GB9914943D0 (en) Methods
GB9908525D0 (en) Methods
EG22820A (en) Bio-geometrical shapes
CA86103S (en) Headboard
CA86102S (en) Headboard
CA88286S (en) Headboard

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011025

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020605

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 01N 37/18 A, 7A 61K 38/00 B, 7A 61K 38/17 B, 7A 61K 38/17 J, 7A 61K 38:43 J

17Q First examination report despatched

Effective date: 20021230

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20041109